{"url":"https://lda.senate.gov/api/v1/filings/b644c7ae-eab0-421a-b7a5-3e0ab978db75/","filing_uuid":"b644c7ae-eab0-421a-b7a5-3e0ab978db75","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2023,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/b644c7ae-eab0-421a-b7a5-3e0ab978db75/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Rawson Warden","dt_posted":"2024-01-21T15:52:50-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1111 19th Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":48827,"url":"https://lda.senate.gov/api/v1/registrants/48827/","house_registrant_id":34528,"name":"OGR","description":"lobbying firm","address_1":"1801 K St NW","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RAWSON WARDEN","contact_telephone":"+1 202-729-4200","dt_updated":"2026-01-30T13:50:08.330534-05:00"},"client":{"id":57383,"url":"https://lda.senate.gov/api/v1/clients/57383/","client_id":57383,"name":"EVERLY HEALTH","general_description":"digital health company","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-09-20"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Regulation of lab developed tests, remote based testing, and telehealth.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57726,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"DEE","last_name":"BUCHANAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38695,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"AGUILLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":3117,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"GIBLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143194,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":"JEN","middle_name":"ALICIA","last_name":"DAULBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66231,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"NOVASCONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":15582,"prefix":null,"prefix_display":null,"first_name":"MOSES","nickname":null,"middle_name":null,"last_name":"MERCADO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":86705,"prefix":null,"prefix_display":null,"first_name":"JEROME","nickname":null,"middle_name":null,"last_name":"MURRAY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60050,"prefix":null,"prefix_display":null,"first_name":"KARISSA","nickname":null,"middle_name":null,"last_name":"WILLHITE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}